SP Elixir (OPC) Private Limited

Human Normal Immunoglobulin for IV Use IP 10% Solution is an immunoglobulin product that contains IgG antibodies derived from human plasma. It is used to treat various immune system deficiencies and autoimmune disorders by providing the body with a broad range of antibodies to fight infections.

It is primarily used for conditions like:

• Primary immunodeficiencies (e.g., common variable immunodeficiency) where the body lacks sufficient antibodies to fight infections.
• Autoimmune disorders such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, and Kawasaki disease.
• Chronic inflammatory demyelinating polyneuropathy (CIDP).

The solution is administered intravenously (IV) under medical supervision, as it is a highly concentrated form of immunoglobulin. The infusion helps boost the immune system in individuals with weak or dysfunctional immunity.

Potential side effects include fever, headache, chills, and mild allergic reactions, so monitoring during administration is crucial. In rare cases, there may be more serious effects like kidney issues or thromboembolic events. Regular monitoring is necessary to ensure the patient’s safety during treatment.

Scapho Secukinumab 150 mg Injection contains secukinumab, a monoclonal antibody used to treat various autoimmune conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. Secukinumab works by inhibiting interleukin-17A (IL-17A), a protein that plays a key role in the inflammatory process associated with these diseases. By blocking IL-17A, it helps to reduce inflammation, relieve symptoms, and improve quality of life. Scapho is administered by subcutaneous injection and the dosage schedule typically starts with loading doses, followed by maintenance doses as prescribed by the healthcare provider.

Guficap 50mg Injection contains capecitabine, an oral chemotherapy agent that is often converted into its active form, 5-fluorouracil (5-FU), in the body. However, when provided in an injectable form, Guficap may be used as part of certain chemotherapy regimens for cancers such as breast cancer, colon cancer, and gastric cancer.

Capecitabine works by inhibiting the synthesis of DNA and RNA in cancer cells, which prevents them from growing and dividing. This helps to slow the progression of the cancer.

The Guficap injection is typically administered intravenously (IV) under the supervision of a healthcare provider, as part of a comprehensive chemotherapy regimen. Common side effects can include nausea, vomiting, fatigue, low blood counts, and hand-foot syndrome (redness, swelling, and pain in the hands or feet).

Because chemotherapy drugs can have significant side effects, regular monitoring and adjustments to the treatment plan may be required.

Ultravist 300mg Injection is a contrast agent used in medical imaging procedures, particularly for X-ray and computed tomography (CT) scans. The active ingredient in Ultravist is iopromide, a non-ionic iodinated contrast medium. It helps enhance the visibility of blood vessels, organs, and tissues, allowing for clearer imaging during diagnostic procedures.

Ultravist 300mg Injection is used in:

• CT scans of the brain, chest, abdomen, and pelvis.
• Angiography (to visualize blood vessels).
• Urography (for imaging the urinary tract).
• Venography (to visualize veins).

It works by temporarily increasing the X-ray absorption of tissues, allowing for better differentiation between structures on the imaging scan. The 300mg refers to the iopromide concentration in the injection, which is typically used in various imaging procedures to achieve adequate contrast.

Administration: Ultravist is injected intravenously by a healthcare professional, typically right before the imaging procedure. The exact dosage depends on the type of imaging, the patient’s size, and the area being examined.

Common side effects include:

• Warmth or flushing during injection
• Nausea or vomiting
• Headache
• Dizziness
• Pain at the injection site

In rare cases, more severe reactions like allergic reactions (e.g., rash, difficulty breathing) may occur. For patients with kidney problems, or those at risk for kidney damage, extra caution is needed.

It's essential to inform the healthcare provider of any pre-existing medical conditions, especially regarding kidney function, as contrast agents like Ultravist can sometimes affect renal health.

Interferon alpha 2a inj